University of Iowa Hospital and Clinics
Iowa City, Iowa, 52242, United States
Location status: Recruiting
NCT Number: NCT04128709
The investigators have developed a novel pressure monitoring device that hooks to standard urinary catheters that are used by patients with a neurogenic bladder on daily clean intermittent catheterization. The device has already been demonstrated to be accurate compared to the gold standard in clinic urodynamics. This study will assess the patients and care givers ability and experience using the device in a home setting.
Interested in participating?
Request Info1 year–99 year
All sexes
Interventional
Not applicable
Iowa City, Iowa, 52242, United States
Location status: Recruiting
For patients with neurogenic bladder, regular monitoring of bladder pressure and capacity is a critical component of maintaining renal and urinary health. This monitoring is currently done by in-office urodynamics testing (UDS). This testing is done intermittently, leaving open the possibility of worsening of bladder function and renal deterioration between testing sessions.
This study utilizes a novel pressure monitoring device which is portable and attaches to the end of a standard urinary catheter. The investigators will be investigating if this device can be used by patients or their caregivers in a home setting.
This study will enroll patients with neurogenic bladder that currently perform clean intermittent catheterization on a daily basis as part of their regular care. The patients will be asked to use the device at least twice a day for two weeks.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The non-invasive device connects to the end of urinary catheter that the patient uses for routine daily catheterization. Once urine flows into the device the patient presses a single button in order to obtain a pressure measurement which is recorded and stored in the device along with the time and date. The measurement(s) can later be transmitted wirelessly to a smart phone that contains an app for the device.
Time frame: Two weeks
Utilization study of novel external device
Contact information is provided by the study sponsor or research team.
Christopher S Cooper, MD
CONTACT
Denise Juhr, BS
CONTACT
Christopher Cooper
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06336304
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Hanover, Maryland, United States
View Trial DetailsNCT05141487
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Cleveland, Ohio, United States
View Trial DetailsNCT06978205
Central Nervous System Diseases, Female Urogenital Diseases
Jinan, Shandong, China
View Trial DetailsNCT03456089
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Iowa City, Iowa, United States
View Trial Details